https://www.globenewswire.com/news-release/2026/05/01/3285820/0/en/noema-pharma-to-present-phase-2a-results-for-cendifensine-in-vasomotor-symptoms-hot-flashes-due-to-menopause-at-the-2026-acog-annual-clinical-scientific-meeting.html
Noema Pharma to Present Phase 2a Results for Cendifensine
BASEL, Switzerland and BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Noema Pharma AG today announced the presentation of Phase 2a study results evaluating...
noemapharmapresentphaseresults